IT1200080B - Dispersione solida di un agente farmaceuticamente attivo, particolarmente diidropiridina, in una matrice cristallina solubile in acqua, composizione farmaceutica che la contiene e processo per la loro preparazione - Google Patents

Dispersione solida di un agente farmaceuticamente attivo, particolarmente diidropiridina, in una matrice cristallina solubile in acqua, composizione farmaceutica che la contiene e processo per la loro preparazione

Info

Publication number
IT1200080B
IT1200080B IT8548210A IT4821085A IT1200080B IT 1200080 B IT1200080 B IT 1200080B IT 8548210 A IT8548210 A IT 8548210A IT 4821085 A IT4821085 A IT 4821085A IT 1200080 B IT1200080 B IT 1200080B
Authority
IT
Italy
Prior art keywords
preparation
pharmaceutical composition
active agent
composition containing
water soluble
Prior art date
Application number
IT8548210A
Other languages
English (en)
Italian (it)
Other versions
IT8548210A0 (it
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8548210A0 publication Critical patent/IT8548210A0/it
Application granted granted Critical
Publication of IT1200080B publication Critical patent/IT1200080B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT8548210A 1984-06-14 1985-06-13 Dispersione solida di un agente farmaceuticamente attivo, particolarmente diidropiridina, in una matrice cristallina solubile in acqua, composizione farmaceutica che la contiene e processo per la loro preparazione IT1200080B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
IT8548210A0 IT8548210A0 (it) 1985-06-13
IT1200080B true IT1200080B (it) 1989-01-05

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8548210A IT1200080B (it) 1984-06-14 1985-06-13 Dispersione solida di un agente farmaceuticamente attivo, particolarmente diidropiridina, in una matrice cristallina solubile in acqua, composizione farmaceutica che la contiene e processo per la loro preparazione

Country Status (21)

Country Link
AT (1) AT391806B (fr)
AU (2) AU587190B2 (fr)
BE (1) BE902626A (fr)
CA (1) CA1264441A (fr)
CY (1) CY1635A (fr)
DE (1) DE3520184C2 (fr)
DK (1) DK167649B1 (fr)
ES (1) ES8702141A1 (fr)
FR (1) FR2565822B1 (fr)
GB (3) GB2160100B (fr)
GR (1) GR851430B (fr)
HK (1) HK25192A (fr)
HU (1) HU198844B (fr)
IE (1) IE58834B1 (fr)
IL (1) IL75490A0 (fr)
IT (1) IT1200080B (fr)
LU (1) LU85946A1 (fr)
NL (1) NL194389C (fr)
NZ (1) NZ212390A (fr)
PT (1) PT80635B (fr)
SE (1) SE504583C2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
WO1989009066A1 (fr) * 1988-03-24 1989-10-05 Bukh Meditec A/S Composition a diffusion regulee
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
ES2322405T3 (es) 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1189599A2 (fr) * 1999-06-11 2002-03-27 Eli Lilly And Company Materiaux pharmaceutiques, leurs techniques de preparation et leurs utilisations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
JP3462490B2 (ja) * 1999-08-04 2003-11-05 山之内製薬株式会社 安定な経口用医薬組成物
AU762291B2 (en) 1999-09-30 2003-06-19 Penwest Pharmaceutical Co. Sustained release matrix systems for highly soluble drugs
CA2434542A1 (fr) * 2001-02-13 2002-08-22 Anne Juppo Nouvelle preparation a liberation modifiee
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (fr) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Procedé pour la préparation des formes de dosage comprenant une dispersion solide d'un agent active microcristalline
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
EP2500015A1 (fr) 2006-12-05 2012-09-19 Landec Corporation Administration de médicaments
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
BRPI0917358A2 (pt) 2008-08-20 2015-11-17 Univ Texas formulação farmacêutica de liberação controlada e método.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
EP0001247A1 (fr) * 1977-09-14 1979-04-04 Kanebo, Ltd. Composition pharmaceutique contenant de la nifédipine et procédé pour sa préparation.
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (fr) * 1981-10-29 1993-02-10 Bayer Ag Procédé de fabrication de préparations pharmaceutiques solides à libération rapide de dihydropyridines
CA1208558A (fr) * 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
LU85946A1 (fr) 1986-01-24
FR2565822B1 (fr) 1989-02-17
SE504583C2 (sv) 1997-03-10
SE8502950D0 (sv) 1985-06-13
IE851460L (en) 1985-12-14
DK167649B1 (da) 1993-12-06
DK264785A (da) 1985-12-15
IL75490A0 (en) 1985-10-31
AT391806B (de) 1990-12-10
CY1635A (en) 1992-11-06
GB8727056D0 (en) 1987-12-23
IE58834B1 (en) 1993-11-17
GR851430B (fr) 1985-11-25
NL8501578A (nl) 1986-01-02
GB2196851A (en) 1988-05-11
SE8502950L (sv) 1985-12-15
AU4348685A (en) 1985-12-19
PT80635A (en) 1985-07-01
GB2196852A (en) 1988-05-11
NZ212390A (en) 1992-02-25
GB2196852B (en) 1989-05-17
GB2160100A (en) 1985-12-18
DK264785D0 (da) 1985-06-12
DE3520184C2 (de) 1997-03-13
GB2160100B (en) 1989-06-01
GB2196851B (en) 1989-06-07
DE3520184A1 (de) 1985-12-19
ES544075A0 (es) 1987-01-01
ES8702141A1 (es) 1987-01-01
GB8727055D0 (en) 1987-12-23
PT80635B (pt) 1987-10-20
GB8514855D0 (en) 1985-07-17
NL194389B (nl) 2001-11-01
BE902626A (fr) 1985-12-10
CA1264441A (fr) 1990-01-16
HK25192A (en) 1992-04-10
HUT40918A (en) 1987-03-30
AU4454389A (en) 1990-03-22
NL194389C (nl) 2002-03-04
IT8548210A0 (it) 1985-06-13
FR2565822A1 (fr) 1985-12-20
AU587190B2 (en) 1989-08-10
ATA174885A (de) 1990-06-15
HU198844B (en) 1989-12-28

Similar Documents

Publication Publication Date Title
IT1200080B (it) Dispersione solida di un agente farmaceuticamente attivo, particolarmente diidropiridina, in una matrice cristallina solubile in acqua, composizione farmaceutica che la contiene e processo per la loro preparazione
IT8547844A1 (it) Tavolette di sostanza attiva farmaceutica che si disgrega rapidamente stabili al magazzinaggio
IT9067443A0 (it) Procedimento per formare una massa refrattaria porosa e composizione di materiale da usare in tale procedimento.
IE880281L (en) Swellable pellets
IT1176613B (it) Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
IE873213L (en) Galenical Formulation
IT1243357B (it) Metodo per preparare una composizione farmaceutica in forma di microparticelle
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
FR2624863B1 (fr) Nouvelle forme cristalline de la ciclosporine, sa preparation et les compositions pharmaceutiques la contenant
IL114335A (en) Pharmacologically active CNS compounds process for their preparation and pharmaceutical compositions containing them
DK455286D0 (da) Farmaceutisk middel med langsom frigaering og fremgangsmaade til dets fremstilling
NO175894C (no) Krystallinske (metallo)silikater og germanater, SUZ-2, fremgangsmåte for deres fremstilling og anvendelse derav
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
FR2615512B1 (fr) Composes de benzamides substitues pharmacologiquement actifs, compositions pharmaceutiques contenant ces composes, et leur procede de preparation
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
KR900700452A (ko) 테트라히드로피리딘 유도체, 그를 함유하는 약학 조성물 및 그의 제조방법
NO985807L (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
AR244243A1 (es) Procedimiento para preparar timolinfotropina.
AU1621788A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
HUT39439A (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
IT8422954A0 (it) Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970623